Author:
Hartshorn K L,Vogt M W,Chou T C,Blumberg R S,Byington R,Schooley R T,Hirsch M S
Abstract
Both recombinant alpha A interferon and azidothymidine inhibit the replication of human immunodeficiency virus in peripheral blood mononuclear cells. Combinations of recombinant alpha A interferon and azidothymidine at concentrations that are easily achievable in patients synergistically inhibit human immunodeficiency virus in vitro with minimal toxicity. Combinations of antiretroviral compounds that act by different mechanisms may prove useful in the treatment of acquired immunodeficiency syndrome-related disorders.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro;Baba M.;Antimicrob. Agents Chemother.,1984
2. Promising results halt trial of anti-AIDS drug;Barnes D. M.;Science,1986
3. A method for testing synergy with any number of agents;Berenbaum M. C.;J. Infect. Dis.,1978
4. Chou J. and T. C. Chou. 1985. Dose-effect analysis with microcomputers: quantitation of ED50 LD50 synergism and antagonism low-dose risk receptor binding and enzyme kinetics. A computer software for Apple II series or IBM PC and manual. Elsevier-Biosoft. Elsevier Science Publishers Cambridge.
5. Quantitative analysis of doseeffect relationships: the combined effects of multiple drugs or enzyme inhibitors;Chou T.;Adv. Enzyme Regul.,1984
Cited by
248 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献